Faculty Information - ISHIYAMA Yuudai

（Last updated : 2026-07-28 13:40:50）

ISHIYAMA Yuudai
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Urology

Position Assistant Professor

■ Published papers

1.	Other	Application of restricted mean survival time analysis to contemporary management of metastatic renal rell carcinoma with immunotherapy－based regimens. 2026/05
2.	Original article	An RMST-based analysis of systemic therapy in muscle-invasive bladder cancer. 2025/10
3.	Original article	Outcomes of enfortumab vedotin treatment in patients ineligible for the EV‐301 trial. 2025/09
4.	Other	A restricted mean survival time based analysis of systemic therapy sequencing in muscle-invasive bladder cancer. 2025/05
5.	Other	Re: Kosuke Takemura, Audreylie Lemelin, Matthew S. Ernst, et al. Outcomes of patients with brain metastases from renal cell carcinoma receiving first-line therapies: Results from the international metastatic renal cell carcinoma database consortium. 2024/12
6.	Original article	Impact of tumor dissecting technique on trifecta achievement in patients requiring extended warm ischemia during robot-assisted partial nephrectomy. 2024/10/18
7.	Case report	Tips for percutaneous nephrolithotomy for transplant kidney stone. 2024/10/13
8.	Other	Reply to: Sebastiano Buti and Giulia Claire Giudice’s letter to the editor Re: Comparing a part to the whole—beware of the disparity of the renal cell carcinoma prognostic models. 2024/09
9.	Original article	Comparative analysis of real-world efficacy and safety of hypoxia-inducible factor prolyl-hydroxylase inhibitors in kidney transplant recipients versus nontransplant individuals: A single-center study. 2024/07
10.	Other	Re: Kosuke Takemura, Matthew S. Ernst, Vishal Navani, et al. Characterization of patients with metastatic renal cell carcinoma undergoing deferred, upfront, or no cytoreductive nephrectomy in the era of combination immunotherapy: Results from the international metastatic renal cell carcinoma database consortium. 2024/06
11.	Other	ASO author refections: Recurrence risk prediction in high‑risk renal cell carcinoma: Where We Stand. 2024/05
12.	Original article	Predicting recurrence after radical surgery for high‑risk renal cell carcinoma: Development and internal validation of the “TOWARDS” score. 2024/05
13.	Original article	Prognostic value of the lung immune prognostic index on recurrence after radical surgery for high-risk renal cell carcinoma. 2024/02/14
14.	Original article	Effects of remote ischemic preconditioning on renal protection in patients undergoing robot-assisted laparoscopic partial nephrectomy. 2023/10
15.	Original article	Association between lung immune prognostic index and survival of patients with metastatic urothelial carcinoma treated with pembrolizumab. 2023/07
16.	Original article	Impact of warm ischemia on acute kidney injury after robotic partial nephrectomy stratified by baseline kidney function. 2023/03
17.	Original article	Impact of body mass index on outcomes in an asian population of advanced renal cell carcinoma and urothelial carcinoma treated with immune checkpoint inhibitors. 2023/02
18.	Original article	New longitudinal component of the RENAL nephrometry score for predicting the operative complexity in transperitoneal robot-assisted partial nephrectomy. 2022/06
19.	Original article	Antibiotic use and survival of patients receiving pembrolizumab for chemotherapy-resistant metastatic urothelial carcinoma 2021/12
20.	Original article	Limited impact of warm ischemic threshold for partial nephrectomy in the robotic surgery era: A propensity score matching study. 2021/12
21.	Original article	Association between ureteral clamping time and acute kidney injury during robot-assisted radical cystectomy. 2021/11
22.	Original article	Greater renal function benefit from enucleation technique for more complex renal tumors in robot-assisted partial nephrectomy. 2021/10
23.	Original article	Surgery for renal cell carcinoma extending to the right atrium in Japanese institutions: Focusing on cardiopulmonary bypass with or without deep hypothermic circulatory arrest. 2021/10
24.	Original article	Albumin-to-alkaline phosphatase ratio as a novel prognostic marker of nivolumab monotherapy for previously treated metastatic renal cell carcinoma. 2021/09
25.	Original article	Therapeutic benefit of lymphadenectomy for older patients with urothelial carcinoma of the upper urinary tract: a propensity score matching study. 2021/04
26.	Original article	Predictive impact of prognostic nutritional index on pembrolizumab for metastatic urothelial carcinoma resistant to platinum-based chemotherapy. 2021/03
27.	Original article	Predictive role of γ‑glutamyltransferase in patients receiving nivolumab therapy for metastatic renal cell carcinoma. 2021/03
Display 5 items
Display all(27)

■ Academic conference presentation

1.	Application of restricted mean survival time analysis to contemporary management of metastatic renal rell carcinoma with immunotherapy－based regimens. （ポスター掲示，一般） 2026/05/18
2.	Predicting recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: Development and validation of the JIKEI-YAYOI score. （ポスター掲示，一般） 2025/10/19
3.	A restricted mean survival time based analysis of systemic therapy sequencing in muscle-invasive bladder cancer. （ポスター掲示，一般） 2025/04/29
4.	Clinicopathological evaluation of living-related kidney transplantation from older adult donors: A focus on zero-time biopsy findings. （ポスター掲示，一般） 2024/06/04
5.	Greater impact of tumor dissecting technique on trifecta achievement in patients requiring extended warm ischemia during robotic-assisted partial nephrectomy. （ポスター掲示，一般） 2024/05/06
6.	Patient and tumor profile differences for early and late recurrences following radical resection for high-risk renal cell carcinoma. （ポスター掲示，一般） 2024/05/05
7.	Prognostic impact of lung immune prognostic index in recurrence after radical surgery for high-risk renal cell carcinoma. （ポスター掲示，一般） 2024/05/05
8.	Predicting recurrence after radical surgery for high-risk renal cell carcinoma: Development and Internal Validation of　“TOWARDS” score. （ポスター掲示，一般） 2024/05/04
9.	Predicting recurrence after radical surgery for high-risk renal cell carcinoma: development and internal validation of "TOWARDS" score. （ポスター掲示） 2024/04/27
10.	Clinical study of RAPN between RENAL Nephrometry Score 2-2-3-3 and 1-3-3-3. （ポスター掲示，一般） 2024/04/26
11.	Introducing robotic approach to radical nephrectomy: single-institution comparison with laparoscopic approach. （ポスター掲示，一般） 2024/04/26
12.	Assessing long-term complications of kidney transplantation without intraoperative ureteral dj stent: A single-center experience. （ポスター掲示，一般） 2023/06/06
13.	Effect of remote ischemic preconditioning on renal protection in patients undergoing robot-assisted laparoscopic partial nephrectomy. （ポスター掲示） 2023/04/21
14.	Impact of warm ischemia on acute kidney injury after robotic partial nephrectomy stratified by baseline kidney function. （口頭） 2023/04/20
15.	Excellent long-term outcome of ABO-incompatible living kidney transplantation by reduced-session of plasmapheresis of desensitization protocol. （ポスター掲示，一般） 2022/06/05
16.	Surgical outcomes for older patients with renal cell carcinoma and inferior vena cava thrombus. （ポスター掲示，一般） 2022/05/16
17.	Efficacy and feasibility of robot-assisted partial nephrectomy for octogenarians: Comparison with younger counterparts. （ポスター掲示，一般） 2022/05/15
18.	Order of thrombectomy for management of renal cell carcinoma with inferior vena cava thrombus. （ポスター掲示，一般） 2022/05/15
19.	Association between immune adverse events and survival of patients with metastatic urothelial carcinoma treated with pembrolizumab. （ポスター掲示，一般） 2022/05/13
20.	Association between ureteral clamping time and acute kidney injury during robot-assisted radical cystectomy. （ポスター掲示，一般） 2022/05/13
21.	C-reactive protein kinetics to predict recurrence after radical surgery for high-risk renal cell carcinoma. （ポスター掲示，一般） 2022/05/13
22.	Safety and efficacy of nivolumab for patients with chronic kidney disease. （口頭，一般） 2020/12/23
23.	Therapeutic benefit of lymphadenectomy during radical nephroureterectomy for elderly patients with upper tract urothelial carcinoma. （口頭，一般） 2020/12/23
24.	Reduced risk of new occurrence or progression of sarcopenia by robot-assisted radical cystectomy compared to the open procedure. （口頭，一般） 2020/12/22
25.	Clinical relevance of immunoglobulin M deposition in peritubular capillaries in ABO-incompatible kidney transplantation. （ポスター掲示，一般） 2020/05/30
26.	The relationship between metformin and post-operative recurrence of renal cell carcinoma （ポスター掲示，一般） 2019/10/24
27.	Immunoglobulin deposition in peritubular capillaries in ABO-incompatible kidney Transplantation （口頭，一般） 2019/10/02
Display 5 items
Display all(27)